Leuprorelin acetate Prescribing at MARKET SURGERY
Sex hormones and hormone antagonists in malignant disease | Malignant Disease and Immunosuppression
Items (12m)
160
Total Quantity
160
NHS Cost
£18.7K
vs National Avg
+245.3%
MARKET SURGERY prescribed 160 items of Leuprorelin acetate over the last 12 months at a cost of £18,710 to the NHS. This is 245.3% above the national average prescribing rate. Leuprorelin acetate is classified under Sex hormones and hormone antagonists in malignant disease in the BNF.
Monthly Prescribing Trend
Jul 2026
17
Jul 2026
11
Jul 2026
13
Jul 2026
14
Jul 2026
11
Jul 2026
18
Jul 2026
13
Jul 2026
14
Jul 2026
15
Jul 2026
9
Jul 2026
12
Jul 2026
13
Prescribing Details
| Total Items | 160 |
|---|---|
| Total Quantity | 160 |
| Total NHS Cost | £18,710 |
| Presentations | 4 different forms |
| vs National Average | +245.3% |
Leuprorelin acetate Prescribing Comparison
| This practice | 160 items |
|---|---|
| National average per practice | 46 items |
| Difference | +245.3% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.